Quetiapine Fumarate Tablet
Product Images NDC 70518-1919

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 70518-1919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

35b3883e Bd69 43d5 8f5a 254dd92cd528 1584 1

FDA Label Image

9fb56acd 2611 4c7d B63f 1de0c57383ea 1628 1

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of Quetlaplne Tablet manufactured by Lupin Ltd in Goa, India. The tablet is in a white capsule form with a dosage of 300 mg. The usual dosage instructions should be found in the insert provided with the medication. It is important to keep this medication and all others out of the reach of children. The tablets should be stored at a temperature between 20-25°C (68-77°F) with excursions allowed between 15-30°C (59-86°F). The batch contains 30 tablets. The NDC for this medication is 68180-0449-02, and it is for prescription use only. Additionally, it has been repackaged by RemedyRepack in Indiana, PA with contact information provided.*
FDA Label Image

A644051f 21f4 4c76 9ed2 E96417d77df9 01

FDA Label Image

A644051f 21f4 4c76 9ed2 E96417d77df9 02

FDA Label Image

A644051f 21f4 4c76 9ed2 E96417d77df9 03

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.